Prostate News Archive
01-Jun-2007
LabCorp licenses prostate cancer detection technology (Pharmaceutical Business Review)
US-based oncology testing development company Laboratory Corporation of America has entered into a license agreement with Veridex to commercialize prostate cancer detection technology. Novacea shares gain on prostate drug deal (Contra Costa Times)
Shares of South San Francisco-based Novacea Inc. surged this week after the firm said it would partner with Schering-Plough Corp. to develop a drug to help treat advanced prostate cancer, the second leading cause of cancer death in men. Dendreon Gets A Fix (Forbes)
Shares jump after company says that its prostate cancer drug could go to market in 2008. Prostate cancer breakthrough (ABC 7 Chicago)
One in six American men will be diagnosed with prostate cancer this year. When the cancer spreads to other parts of the body, standard treatments like chemo and radiation don't always work. But a new drug made from a patient's own cells is giving men new hope.
Back to Prostate News Archive
